HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
about
Foetal and neonatal alloimmune thrombocytopaeniaFetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy.Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease.HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases.The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations.HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases.Studies on the HLA Class-II Antigens of a Patient Presenting a Double Alloimmunization Following Posttransfusion Purpura.Fetal and neonatal thrombocytopenia.Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.Modeling and molecular dynamics of HPA-1a and -1b polymorphisms: effects on the structure of the β3 subunit of the αIIbβ3 integrin.Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT).Maternal alloimmunization against fetal platelet antigens: a prospective study.Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study.Post-transfusion purpura: a survey of 12 Danish cases with special reference to immunoglobulin G subclasses of the platelet antibodies.Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia.The immune response to the HPA-1a antigen: association with HLA-DRw52a.Human platelet-specific alloantigens: update.Evaluation of serological platelet antibody assays.Screening programmes for foetomaternal alloimmune thrombocytopenia.The HLA system: genetics, immunology, clinical testing, and clinical implications.Placental immunology and maternal alloimmune responses.HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies.A vitronectin-receptor-related molecule in human placental brush border membranes.Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?
P2860
Q21203031-CDB205A6-9A8A-4FAD-AD13-0F9F1A93221FQ33351609-91DC1FCC-230D-4C8A-88BF-DA41292E3675Q33360549-AA93424C-B710-491D-99C5-F258DFC1FB8CQ33360919-4104A905-4F23-452A-BF5B-6D12B526581BQ33376320-A055A46D-5521-4F4D-9D17-96078A72993EQ33380911-78529ACB-6726-4CE4-ABD5-93C83D38796CQ33392621-870E59D4-945B-45A6-ABB4-3B48E739F72FQ33392634-BB95EF0A-F58D-448A-9BC8-31FD1F685FE2Q33401637-D65C2867-FBAE-410F-95AC-02170EC33E3BQ33404386-5E2085FD-5FDD-4194-892F-6579DC30AF5FQ33411662-E9E3A5E2-37EF-4ADF-B6ED-D347323C8487Q33426745-C8B127F3-7257-4125-9BB5-BBEC19DAA66DQ33435753-81B4CD16-9D63-4DCF-83B3-C6DE56BA65A4Q33436061-E33438B6-03D6-4B8F-9CA8-81FAA38B61F3Q33437901-2BE7C4DD-564D-4E4B-90F0-B12CE66EA954Q33441520-C7281D85-5D04-4AE1-ACCA-AA25AFF928ABQ33443448-A18221B2-C84B-4F5B-9D47-3CB2B9E59B50Q33488972-93F38B55-C6AF-4089-9EEA-69B7B9B2E2A4Q33489976-98800DD8-9C9A-46B6-A1F1-2A1A8CD4EA6DQ33491554-FDE0C93E-077C-4C67-9499-67D1D07FF2F2Q33497352-97F2A6C3-99FB-4E89-B144-7989E79668EFQ33500029-B86EC7C7-37C0-4017-9418-BEBB6E86DBE1Q33503320-F07BCC48-DFC6-458A-8C18-C7D22F2058B5Q33503325-E6CF86BB-5539-4A0A-8DE7-D1AAC4147ECDQ33503330-DA7AC9A3-6155-48BF-AEE6-3435743C81E9Q36746594-6E630E1F-D4C9-4963-9C8B-FA62B5D19309Q37925148-88933CEB-8618-4334-8C91-B11DC724CCC1Q39042289-C3D35B36-62E8-4612-B35D-7DFCCF7A90D6Q42467482-E25DA53C-5F8B-4368-BF72-85BE467A96A7Q48004033-737419AA-4F0D-4906-A142-5F6B006BC714
P2860
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@ast
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@en
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@nl
type
label
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@ast
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@en
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@nl
prefLabel
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@ast
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@en
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@nl
P2093
P1433
P1476
HLA-DRw52a is involved in alloimmunization against PL-A1 antigen
@en
P2093
A Vergracht
D Blanchard
J D Bignon
J Y Muller
M F Reznikoff-Etievant
M L Cheneau
N Valentin
P356
10.1016/0198-8859(90)90104-W
P407
P577
1990-02-01T00:00:00Z